An observational study investigating renal impact of ledipasvir/sofosbuvir in HIV/HCV co-infected patients treated with tenofovir combined with a boosted protease inhibitor: a real life study
Latest Information Update: 30 Dec 2016
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
Most Recent Events
- 30 Dec 2016 New trial record